Discovery of novel uridine-based chitin synthase inhibitors: Design, synthesis and structure-activity relationships
Abstract
Background: Chitin synthase (CHS) enables the construction of fungi cell wall and insect skeleton by catalyzing the formation of chitin. CHS inhibitor (CHSI) disrupts the integrity of these structural barriers, leading to fungal cell lysis. Notably, CHSIs are considered non-toxic to vertebrates, making CHS a promising target for the development of novel antifungal agents.
Results: Thirty-three novel uridine-based derivatives (UDs) were designed and synthesized through fragment-based drug design (FBDD) to discover potential CHSIs. Bioassays demonstrated that most of the synthesized compounds exhibited excellent fungicidal activity against Alternaria alternata and Botrytis cinerea, with inhibition rates exceeding 80% at 100 μg mL-1. Specifically, compound 5a showed significantly stronger fungicidal activity (EC50 = 0.78 μg mL-1) than the commercial CHSI fungicide polyoxin B (EC50 = 46.56 μg mL-1). In vivo antifungal assays revealed that compound 5a effectively suppressed the infection of Alternaria alternata and Botrytis cinerea, outperforming the positive control. SEM and TEM analyses indicated that compound 5a disrupted the fungal cell wall and membrane. Enzyme inhibition assays confirmed that compound 5a exhibited superior CHS inhibitory activity (IC50 = 1.47 μg mL-1) compared to polyoxin B (IC50 = 1.84 μg mL-1), and molecular docking simulations demonstrated a stronger binding affinity of compound 5a to CHS relative to polyoxin B. A 3D-QSAR model was established to…
Read the paper
Related studies
- Ferulic acid regulates the AKT/GSK-3β/CRMP-2 signaling pathway in a middle cerebral artery occlusion animal model
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
- Photochemical behavior of levofloxacin
- Correlation Between Dissolution Profiles of Salt-Form Drugs in Biorelevant Bicarbonate Buffer and Oral Drug Absorption: Importance of Dose/ Fluid Volume Ratio
- Evaluation of the synergistic potential and mechanisms of action for de novo designed cationic antimicrobial peptides
- Synthesis of [11C]levofloxacin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.